1st Edition

Biological and Pharmacological Properties of the Genus Moringa

  • Available for pre-order. Item will ship after November 2, 2021
ISBN 9780367621407
November 2, 2021 Forthcoming by CRC Press
224 Pages 5 Color & 12 B/W Illustrations

USD $150.00

Prices & shipping based on shipping country


Book Description

There is an increasing interest in plants of the Moringa genus used as a source of phytochemicals with biopharmaceutical potential, as a functional ingredient in many products and as an additive in poultry feeding stocks. Biological and Pharmacological Properties of the Genus Moringa is the first publication to comprehensively assess the latest research on Moringa studies. This book reviews recent studies covering the botanical, agronomical, genomic, biotechnological, and ethnopharmacological aspects. It presents specialized work in a user-friendly way that will appeal to undergraduates, graduates and researchers primarily in ethnopharmacology, functional foods and with a linkage to veterinary treatments.

Key Features:

  • Describes the ethnopharmacological and ethnobotanical use of plants from all Moringa species
  • Presents recent information that will be helpful for the future development of biopharmaceuticals
  • Reviews the phytochemical content from all Moringa species
  • Assesses the potential of all Moringa species as a functional ingredient

Table of Contents

Chapter 1: The Moringa Genus: Botanical and Agricultural Research

Luisa Fernanda Madrigales Reátiga, Roberto Gutiérrez Dorado, Janitzio Xiomara K. Perales Sánchez, Cuauhtémoc Reyes Moreno

1.1. Introduction

1.2.Botanical description

1.2.1.      Taxonomy

1.2.2.      Morphological characteristics

1.2.3.      Moringa oleifera Lam

1.3. Occurrence and distribution

1.4. Agricultural research

1.4.1.      Cultivation and propagation

1.4.2.      Pests and diseases

1.5. Conclusions


Chapter 2: Genetic diversity of the Moringa genus

Liseth Daniela Jaimes-Rangel, Diana Marcela Arias-Moreno, Abraham Cruz-Mendívil,

2.1. Introduction

2.2. Molecular markers

2.2.1.      Restriction fragment length polymorphism (RFLP)

2.2.2.      Randomly amplified polymorphic DNA (RAPD)

2.2.3.      Amplified fragment length polymorphism (AFLP)

2.2.4.      Microsatellites

2.2.5.      Inter simple sequence repeat (ISSR)

2.2.6.      Randomly amplified microsatellite polymorphism (RAMP)

2.2.7.      Sequence-related amplified polymorphism (SRAP)

2.2.8.      Internal transcribed spacer (ITS)

2.2.9.      Start codon targeted polymorphism (SCoT)

2.2.10.  Cytochrome P450 (CytP450)

2.2.11.  Single nucleotide polymorphism (SNPs)

2.3. Genetic diversity of the Moringa genus using molecular markers

2.3.1.      Moringa oleifera

2.3.2.      Moringa peregrina

2.3.3.      Moringa stenopetala

2.3.4.      Moringa ovalifolia

2.4. Advantages and limitations of molecular markers used to analyze the genetic diversity in Moringa species

2.5. Conservation and breeding of Moringa species using molecular markers

2.6. Perspectives

2.7. Conclusions


Chapter 3. Agronomical Aspects of Moringa oleifera (Moringa)

Ramón Ignacio Castillo-López, Elvia Paulina Pérez-Rivera, Julio Montes-Ávila, Jesús José Portillo-Loera, Carlos Bell Castro-Tamayo


3.2. Environmental adaptation

3.2.1.      Variants

3.3. Flowering and fruiting

3.4. Phenological characterization of Moringa oleifera

3.5. Edaphoclimatic requirements

3.5.1.      Soil

3.5.2.      Water

3.5.3.      Temperature

3.6. Particularities of the crop

3.6.1.      Crop propagation methods

3.6.2.      Plantation Seed selection Seed activation Planting methods

3.6.3.      Sowing

3.6.4.      Compost and fertilization

3.6.5.      Pruning

3.6.6.      Harvest Foliage harvest Pods Seed

3.7. Leaf quality parameters

3.8. Crop pests and diseases

3.9. Agronomic and nutritional advantages of Moringa over other crops

3.10.        Aspects and economic importance of the Moringa cultivation

3.11.        Future agro-industrial applications

3.12.        Conclusion


Chapter 4: Moringa – Phytochemical and health benefits

R. Baeza-Jiménez, R. Flores-Flores, M.A. Morales-Ovando and Leticia X. López-Martínez

4.1. Introduction

4.2. Chemical composition of Moringa

4.3. Phytochemicals

4.3.1.      Phenolic acids

4.3.2.      Flavonoids

4.3.3.      Tannins

4.3.4.      Glucosinolates

4.3.5.      Sterols

4.3.6.      Fatty acids

4.4. Applications

4.4.1.      Antioxidant activity

4.4.2.      Antimicrobial potential

4.4.3.      Antiviral activity

4.4.4.      Modulation of blood glucose

4.4.5.      Anti-inflammatory activity

4.4.6.      Anticancer activity

4.4.7.      Other activities

4.5. Conclusion


Chapter 5. Quality Control and Safety of Moringa

Leticia X. López-Martínez, Jesus A. Dominguez-Avila , Norma Julieta Salazar-Lopez  and Gustavo A. Gonzalez-Aguilar

5.1. Introduction

5.2. Regulation of Moringa products

5.3. Safety of Moringa

5.3.1.      Trials in animals

5.3.2.      Human trials

5.4. Quality control of Moringa products

5.4.1.      Heavy metals

5.4.2.      Pesticides

5.4.3.      Microbiology

5.5. Conclusion



Chapter 6: Phytochemicals from Moringa Species

Luis A. Cabanillas-Bojórquez, Erick Paul Gutiérrez-Grijalva, Melissa García-Carrasco, J. Basilio Heredia

6.1. Introduction

6.2. Polyphenol compounds from Moringa species

6.3. Carotenoids from Moringa species

6.4. Other phytochemicals from Moringa species

6.5. Perspectives

6.6. Conclusion


Chapter 7:  Peptides: The Other Bioactive Constituents of Moringa

Sara Avilés-Gaxiola, J. Basilio Heredia

7.1. Moringa oleifera protein generalities

7.2. Moringa oleifera peptides generation, isolation, and identification

7.3. Biological potential of Moringa oleifera peptides

7.3.1.      Antioxidant capacity

7.3.2.      Antidiabetic capacity

7.3.3.      Antihypertensive capacity

7.3.4.      Antifungal activity

7.3.5.      Antibacterial activity

7.3.6.      Antiprotozoal activity

7.3.7.      Antitermitic activity

7.4. Conclusions


Chapter 8: Antioxidant Properties of Moringa Species

Laura A. Contreras-Angulo, Alexis Emus-Medina, Manuel Bernal-Millan, J. Basilio Heredia, Erick P. Gutiérrez-Grijalva

8.1. Introduction

8.2. Botanical description of Moringa species

8.2.1.      Species group “bottle trees”

8.2.2.      Species group “slender trees”

8.2.3.      Species group “tuberous shrubs”

8.3. Bioactive compounds from Moringa species

8.3.1.      Phenolic acids

8.3.2.      Flavonoids

8.3.3.      Carotenoids

8.3.4.      Glucosinolates

8.4. Antioxidant properties of Moringa species

8.4.1.      In vitro studies

8.4.2.      In vivo studies

8.5. Conclusions



Chapter 9: Anti-inflammatory Properties of Moringa oleifera

Rosmarbel Morales-Nava, Janet Alejandra Gutiérrez-Uribe

9.1. Introduction: background and driving forces

9.2. In vitro studies

9.2.1.      Moringa oleifera leaves

9.2.2.      Moringa oleifera bark/wood/stem

9.2.3.      Moringa oleifera roots

9.2.4.      Moringa oleifera flowers and pods

9.3. In vivo studies

9.3.1.      Moringa oleifera leaves

9.3.2.      Moringa oleifera bark/wood/stem

9.3.3.      Moringa oleifera seeds and roots

9.3.4.      Moringa oleifera flowers

9.4. Concluding remarks


Chapter 10:  Anti-diabetic and anti-obesity properties of Moringa species

Manuel A. Picos-Salas, Luis A. Montoya-Inzunza, Cristina Alicia Elizalde-Romero, Erick P. Gutiérrez-Grijalva

10.1. Diabetes, obesity, and their impact on health

10.2. The Moringa genus

10.3. Antidiabetic properties of Moringa species

10.3.1.  In vitro antidiabetic studies                    α-Glucosidase inhibition                    α-Amylase inhibition                    Dipeptidyl peptidase-4-inhibition                    Other in vitro antidiabetic studies

10.4. In vivo antidiabetic studies

10.5.Anti-obesity properties of Moringa species

10.5.1.  In vitro anti-obesity studies

10.5.2.  In vivo anti-obesity studies

10.6. Conclusions


Chapter 11: Perspectives on the Study of Moringa

Erick P. Gutiérrez-Grijalva, J. Basilio Heredia

11.1. Introduction



View More



J. Basilio Heredia, PhD is a Researcher at the Centro de Investigación en Alimentación y Desarrollo, A. C. His research lines focus on plant secondary metabolism, functional foods and nutraceuticals, as well as in food science and technology (conventional and emerging). He has an h-index of 21 in ResearchGate (RG score 32.46), 16 in Web of Science and 16 in Scopus databases.

Dr. Erick P. Gutiérrez-Grijalva is a CONACYT Research Fellow at the Centro de Investigación en Alimentación y Desarrollo, A.C.; he is currently studying the metabolomics, bioactivity, and bioavailability of phytochemicals from plants of the Northwestern region of Mexico with biopharmaceutical potential against noncommunicable diseases. He has an h-index of 8 in ResearchGate (RG score 23.33), 7 in Web of Science and 8 in Scopus databases.